Shares in Aehr Test Systems (AEHR -9.88%) rose 15.4% in the week to Friday morning. The reasons behind the move will have to come down to speculation, as there's no hard, fundamental news about the stock in the last week. Still, Aehr is somewhat of a proxy for the theme of investing in the growth of AI semiconductor spending, and that's probably why there's been speculative buying this week.
Why Aehr Test Systems shares rose this week
As a reminder, Aehr Test Systems makes test equipment and systems that help semiconductor manufacturers ensure reliability and quality. It's also a company that has successfully transitioned its focus from the electric vehicle (EV) market to the AI processor market, in line with shifts in end demand.
NASDAQ: AEHR
Key Data Points
The company is known for being tight-lipped about its customers for commercial reasons and lists customers who have been responsible for at least 10% of its revenue in terms of "Customer A" to "Customer G" in its SEC filings. As such, investors are always left playing the guessing game of who its customers might be. That's a big issue, considering how small the company is, with just $50 million in revenue in its recently completed 2026 financial year. In other words, every major order (bookings were $60.7 million in the fourth quarter of 2026) is a game changer.
Image source: Getty Images.
Aehr's customers reporting?
Management refers to two lead customers in its reporting. One is a leading hyperscaler developing AI processors, and the other is an AI production customer developing silicon photonics technology. Given that Alphabet's Google and Intel could fit the profile of these two unnamed customers, and that both reported this week, it's possible investors bought into Aehr in anticipation of these two companies announcing ramp-ups in capital spending that might be beneficial to Aehr.
As long as momentum continues to build toward a ramp in AI spending, then stocks like Aehr will find favor among investors, and vice versa if the market starts slowing.
